Literature DB >> 10450174

Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.

F E Clode1, M E Kaufmann, H Malnick, T L Pitt.   

Abstract

AIMS: To evaluate three oligonucleotide primer pairs--two specific for 16S and 23S rRNA sequences of Burkholderia cepacia, and the third specific for internal transcribed spacer region of 16S-23S sequences of B gladioli--for the identification and differentiation of reference and clinical strains of these and other species.
METHODS: The three primers sets were applied in polymerase chain reaction (PCR) to a collection of 177 clinical isolates submitted for identification from diagnostic laboratories as presumed B cepacia.
RESULTS: At an annealing temperature of 63 degrees C, all eight B cepacia and four B gladioli reference strains reacted with their specific primers. B vandii was the only other species that was positive with both B cepacia primers but five Burkholderia or Ralstonia species reacted with one of these primers. Seventy eight isolates were typical of B cepacia in biochemical tests and 75 of these reacted with specific primers; three, however, were positive with the B gladioli primers. Fifteen asaccharolytic isolates were confirmed as B cepacia by PCR but other non-fermenting Gram negative species were negative with each of the primers.
CONCLUSIONS: PCR using 16S rRNA sequences is recommended for identification of B cepacia that give atypical results in biochemical tests.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450174      PMCID: PMC501074          DOI: 10.1136/jcp.52.3.173

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. Nov.: Proposal of Ralstonia pickettii (Ralston, Palleroni and Doudoroff 1973) comb. Nov., Ralstonia solanacearum (Smith 1896) comb. Nov. and Ralstonia eutropha (Davis 1969) comb. Nov.

Authors:  E Yabuuchi; Y Kosako; I Yano; H Hotta; Y Nishiuchi
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

Review 2.  Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation.

Authors:  S U Khan; S M Gordon; P C Stillwell; T J Kirby; A C Arroliga
Journal:  Pediatr Infect Dis J       Date:  1996-07       Impact factor: 2.129

3.  Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.

Authors:  G R Hutchinson; S Parker; J A Pryor; F Duncan-Skingle; P N Hoffman; M E Hodson; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

4.  Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli.

Authors:  I A Baxter; P A Lambert; I N Simpson
Journal:  J Antimicrob Chemother       Date:  1997-02       Impact factor: 5.790

5.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

Review 6.  Burkholderia cepacia: medical, taxonomic and ecological issues.

Authors:  J R Govan; J E Hughes; P Vandamme
Journal:  J Med Microbiol       Date:  1996-12       Impact factor: 2.472

7.  Detection of Pseudomonas (Burkholderia) cepacia using PCR.

Authors:  P W Campbell; J A Phillips; G J Heidecker; M R Krishnamani; R Zahorchak; T L Stull
Journal:  Pediatr Pulmonol       Date:  1995-07

8.  The identification of Pseudomonas cepacia and its occurrence in clinical material.

Authors:  B Holmes
Journal:  J Appl Bacteriol       Date:  1986-10

9.  Phylogenetic evidence for the transfer of Pseudomonas cocovenenans (van Damme et al. 1960) to the genus Burkholderia as Burkholderia cocovenenans (van Damme et al. 1960) comb. nov.

Authors:  N Zhao; C Qu; E Wang; W Chen
Journal:  Int J Syst Bacteriol       Date:  1995-07

10.  Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.

Authors:  D R Burdge; M A Noble; M E Campbell; V L Krell; D P Speert
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

View more
  9 in total

1.  Identification of members of the Burkholderia cepacia complex by species-specific PCR.

Authors:  P W Whitby; K B Carter; K L Hatter; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.

Authors:  Agnes Ferroni; Isabelle Sermet-Gaudelus; Eric Abachin; Gilles Quesne; Gerard Lenoir; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.

Authors:  A McDowell; E Mahenthiralingam; J E Moore; K E Dunbar; A K Webb; M E Dodd; S L Martin; B C Millar; C J Scott; M Crowe; J S Elborn
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

4.  Distribution of genes encoding putative transmissibility factors among epidemic and nonepidemic strains of Burkholderia cepacia from cystic fibrosis patients in the United Kingdom.

Authors:  F E Clode; M E Kaufmann; H Malnick; T L Pitt
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

5.  Toxoflavin Produced by Burkholderia gladioli from Lycoris aurea Is a New Broad-Spectrum Fungicide.

Authors:  Xiaodan Li; Yikui Li; Ren Wang; Qizhi Wang; Ling Lu
Journal:  Appl Environ Microbiol       Date:  2019-04-18       Impact factor: 4.792

6.  Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Authors:  Christine Segonds; Patricia Clavel-Batut; Michelle Thouverez; Dominique Grenet; Alain Le Coustumier; Patrick Plésiat; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

7.  Clinical and environmental Burkholderia strains: biofilm production and intracellular survival.

Authors:  Dianella Savoia; Mario Zucca
Journal:  Curr Microbiol       Date:  2007-04-24       Impact factor: 2.188

8.  Fatal 3-Nitropropionic Acid Poisoning after Consuming Coconut Water.

Authors:  Thomas Birkelund; Rakel F Johansen; Dorte G Illum; Stig Eric Dyrskog; Jakob A Østergaard; Travis M Falconer; Chris Andersen; Helena Fridholm; Søren Overballe-Petersen; Jørgen S Jensen
Journal:  Emerg Infect Dis       Date:  2021-01       Impact factor: 6.883

9.  Pan-Genome Analysis Reveals Host-Specific Functional Divergences in Burkholderia gladioli.

Authors:  Hyun-Hee Lee; Jungwook Park; Hyejung Jung; Young-Su Seo
Journal:  Microorganisms       Date:  2021-05-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.